Cover Image

Therapeutic potential of polyphenols against aging- induced idiopathic pulmonary fibrosis (IPF) via Bioinformatics analysis

Background: Hyperactivation of Akt/mTORC1 is known to be the mechanistic driver for idiopathic pulmonary fibrosis (IPF) induction in elderly population. Stimulation of Aryl hydrocarbon receptor (AhR) under physiological stress is largely associated with Akt/mTORC1 inhibition upon aging. This in turn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ankit Tripathi (Author), Deepika Tripathi (Author), Manish Shukla (Author), Meenakshi Sharma (Author)
Format:	Book
Published:	Elsevier, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
by: Shaney L. Barratt, et al.
Published: (2018)

The role of nintedanib and pirfenidone in the treatment of idiopathic pulmonary fibrosis and review of recent clinical trials of IPF therapy
by: Michał Żuber, et al.
Published: (2024)

Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
by: Angelo Zinellu, et al.
Published: (2024)

Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?
by: C. Veith, et al.
Published: (2023)

Update on therapeutic management of idiopathic pulmonary fibrosis
by: Tzouvelekis A, et al.
Published: (2015)

Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
by: Yu Fujita
Published: (2022)

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
by: Jun Chang, et al.
Published: (2023)

Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
by: Aditi Chaudhary, et al.
Published: (2023)

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
by: Cao X, et al.
Published: (2021)

Idiopathic Pulmonary Fibrosis
Published: (2022)

Correction: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
by: Jun Chang, et al.
Published: (2024)

Therapeutic Potential of Polyphenols in Cardiac Fibrosis
by: Ning Zhang, et al.
Published: (2018)

Protective mechanism of flavonoids of Oxytropis falcata bunge against IPF
by: Yan-jun Wang, et al.
Published: (2021)

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
by: Cristina Estornut, et al.
Published: (2022)

Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches
by: Ilma Shakeel, et al.
Published: (2023)

Cough in Idiopathic Pulmonary Fibrosis
by: Jennifer Mann, et al.
Published: (2021)

Management of Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
by: Abdullah Rashed Alharbi
Published: (2024)

State of the Art in Idiopathic Pulmonary Fibrosis
Published: (2023)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
by: Qianru Mei, et al.
Published: (2022)

Pirfenidone treatment of idiopathic pulmonary fibrosis
by: Ye Gan, et al.
Published: (2011)

Prospects for Treatment of Idiopathic Pulmonary Fibrosis
by: R. N. Mustafin
Published: (2022)

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
by: Francesca Ruscitti, et al.
Published: (2020)

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
by: Hongbo Ma, et al.
Published: (2022)

MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics
by: Huimin Li, et al.
Published: (2016)

Pulmonary fibroblast-specific delivery of siRNA exploiting exosomes-based nanoscaffolds for IPF treatment
by: Haoyu Lu, et al.
Published: (2024)

Idiopathic pulmonary fibrosis and GERD: links and risks
by: Ghisa M, et al.
Published: (2019)

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
by: Ana eCamelo, et al.
Published: (2014)

Small airway dysfunction in idiopathic pulmonary fibrosis
by: Chengsheng Yin, et al.
Published: (2022)

IPF-Acute Exacerbations: Advances and Future Perspectives
by: Spyros A. Papiris, et al.
Published: (2022)

Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis
by: Zheyi Xiang, et al.
Published: (2023)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
by: Wencheng Yu, et al.
Published: (2017)

Idiopathic pulmonary fibrosis - novel approach on future treatment
by: Katarzyna Pacek, et al.
Published: (2023)

Current and novel drug therapies for idiopathic pulmonary fibrosis
by: Adamali HI, et al.
Published: (2012)

The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
by: Jiahui Zhu, et al.
Published: (2022)

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
by: Xudan Yang, et al.
Published: (2023)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014)

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Dong Weng, et al.
Published: (2019)

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
by: Nathan SD, et al.
Published: (2014)

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland
by: Katarzyna Górska, et al.
Published: (2022)

Divergent roles of the Hippo pathway in the pathogenesis of idiopathic pulmonary fibrosis: tissue homeostasis and fibrosis
by: Ryusuke Kizawa, et al.
Published: (2023)